SH – ViewMind Inc Related Content
Overcoming global inequities in cognitive healthcare to combat dementia
CEO of ViewMind Inc, Mark Edwards, discusses overcoming global inequities in cognitive healthcare to combat the dementia epidemic.
What is the optimal window for the early detection of Alzheimer’s disease?
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
Cracking the cognitive effects of Long COVID
CEO of ViewMind Inc, Mark Edwards, discusses the cognitive effects of Long COVID, aiming to understand the science behind brain fog and other COVID symptoms.
Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
